Trademark: 97353799
Word
AOBIOME
Status
Pending
Status Code
731
Status Date
Thursday, May 2, 2024
Serial Number
97353799
Mark Type
4
Filing Date
Friday, April 8, 2022
Published for Opposition
Tuesday, March 7, 2023

Trademark Owner History
AOBIOME LLC - Owner At Publication

Classifications
5 Medicated gels for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated creams for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated sprays for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; nasal sprays for therapeutic use; topical applications in the nature of gels, creams, sprays, and liquids for therapeutic use, namely, topical preparations containing ammonia oxidizing bacteria for the treatment of skin disorders, acne, inflammation, eye disorders, migraines, headaches, allergic reactions, insomnia, hypertension, thermoregulation, and to promote wound healing; medicated liquids for therapeutic use in the nature of therapeutic pharmaceuticals for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; biological therapeutics being pharmaceutical preparations for treatment of skin disorders, circulatory and cardiovascular disorders, neurologic diseases, inflammation, gastrointestinal disorders, respiratory disorders, eye disorders, urogenital disorders, auditory disorders, migraines, headaches, allergic rhinitis, insomnia, hyperhidrosis, acne, and hypertension; therapeutic agents for thermoregulation and promoting wound healing
10 Stents; intra-uterine contraceptive devices; catheters; pessaries; coatings sold as an integral component of medical stents and other implantable medical devices

Trademark Events
Apr 12, 2022
New Application Entered
Apr 12, 2022
New Application Office Supplied Data Entered
Jan 26, 2023
Assigned To Examiner
Jan 27, 2023
Approved For Pub - Principal Register
Mar 7, 2023
Published For Opposition
Mar 7, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 15, 2023
Notification Of Notice Of Publication E-Mailed
May 2, 2023
Noa E-Mailed - Sou Required From Applicant
Oct 26, 2023
Notice Of Approval Of Extension Request E-Mailed
May 2, 2024
Sou Teas Extension Received
May 2, 2024
Sou Extension 2 Filed
May 2, 2024
Sou Extension 2 Granted
May 3, 2024
Notice Of Approval Of Extension Request E-Mailed
Oct 24, 2023
Sou Extension 1 Granted
Oct 24, 2023
Sou Teas Extension Received
Oct 24, 2023
Sou Extension 1 Filed

Trademark Alertz updated from USPTO on 2030-01-24